SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Longer term short term day trades.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Steve Felix9/23/2021 7:51:37 PM
   of 1927
 
New: just a few to keep an eye on for now. This could be a while.

09/23/2021 14:36:12 Bought 58 CFMS @ 1.47 -85.26
09/23/2021 14:42:13 Bought 142 CFMS @ 1.47 -208.74

Took a $2k hit on 900 shares of this one back in 2019. Yikes!

From 3 days ago:

Conformis, Inc. (NASDAQ:CFMS) provided today an update of its third quarter revenue performance
expectations in advance of the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit ("OpCo
Summit"). The Company has experienced higher than expected levels of deferred and rescheduled knee
and hip procedures as a result of the surge in COVID-19 cases associated with the Delta variant.
Accordingly, the Company has updated its revenue outlook for the third quarter. Conformis now
expects product revenue for the quarter to be approximately $13.7 million to $14.3 million. This
compares to the $15.5 million to $16.5 million projection announced on August 4, 2021.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext